F12.21 Cannabis dependence, in remission F12.21 is used when an individual previously met criteria for cannabis dependence but no longer meets full criteria, with the exception that craving may still be present
The outcome is slower neutralization of acid entering the esophagus, enabling prolonged irritation and heightening esophageal damage risk
For these reasons, it is appropriate to establish benchmarks for Medicare CQMs that are consistent with MIPS benchmarking policies
As many episodes of therapy treatment are completed in less than 30 calendar days, we expect that physicians and NPPs will continue to certify plans of care that appropriately estimate the duration of needed therapy treatment for a patient, even if the duration is less than 90 days
They may refer you to a gastroenterologist, a specialist in the GI tract, to diagnose you